India  

EU eyes overhaul of pharma rules to tackle vaccine, antibiotic shortages

Reuters India Tuesday, 2 June 2020
The European Commission on Tuesday started a process that could lead to reforms of drug manufacturing to limit shortages of vaccines and antibiotics and make medicines more easily available.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

European Commission European Commission Executive branch of the European Union

Explainer: Why is the EU Commission betting on hydrogen for a greener future? [Video]

Explainer: Why is the EU Commission betting on hydrogen for a greener future?

Explainer: Why is the EU Commission betting on hydrogen for a greener future?

Credit: Euronews English    Duration: 01:35Published
15th meeting of India-EU summit will be held in virtual mode on July 15: MEA [Video]

15th meeting of India-EU summit will be held in virtual mode on July 15: MEA

The official spokesperson of Ministry of External Affairs (MEA), Anurag Srivastava informed that 15th meeting of India-EU summit will be held in virtual mode on 15 July. Anurag Srivastava said, "The 15th meeting of India-EU summit will be held in virtual mode on 15 July. It will be co-chaired by Prime Minister, President of European Council and President of European Commission. The summit will review India-EU cooperation, also expected to discuss developments around COVID."

Credit: ANI    Duration: 01:00Published
EU to experience 'even deeper recession' than anticipated, as new forecast predicts 8.7% contraction [Video]

EU to experience 'even deeper recession' than anticipated, as new forecast predicts 8.7% contraction

The European Commission announced that the euro area economy will contract by 8.7%, as the lifting of lockdown measures has been more gradual than expected.View on euronews

Credit: euronews (in English)    Duration: 02:11Published
Gilead's remdesivir gets conditional EU clearance [Video]

Gilead's remdesivir gets conditional EU clearance

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.

Credit: Reuters Studio    Duration: 00:59Published
Coronavirus: EU launches legal action against 10 countries over cancelled flights compensation [Video]

Coronavirus: EU launches legal action against 10 countries over cancelled flights compensation

The European Commission says too many passengers whose flights were cancelled amid the COVID-19 pandemic have not been refunded on time or have been offered only vouchers, in violation of EU rules.View on euronews

Credit: euronews (in English)    Duration: 01:35Published

European Union European Union Economic and political union of European states

Brexit: UK to spend €790m on new GB-EU border control systems ready for 2021 [Video]

Brexit: UK to spend €790m on new GB-EU border control systems ready for 2021

Brexit: UK to spend €790m on new GB-EU border control systems ready for 2021

Credit: Euronews English    Duration: 01:29Published
Government announces £700m for Britain-EU border [Video]

Government announces £700m for Britain-EU border

More than £700 million is to be spent on building new infrastructure, hiring staff and developing technology to ensure Britain’s border systems are fully operational when the UK leaves the EU at the end of the year.Cabinet Office Minister Michael Gove said the major investment would ensure traders and the border industry are able to “manage the changes and seize the opportunities” when the transition period ends in December.

Credit: PA - Press Association STUDIO    Duration: 00:48Published

Related news from verified sources

COVID-19 vaccine development moving positively, next one month crucial: Bharat Biotech

The Covid-19 vaccine development is moving in a positive direction, next one month is very crucial, said Dr. Krishna Mohan Ella, Chief Executive Officer of...
Mid-Day

Shrinking rate of fresh COVID-19 infections creates bizarre problem for vaccine developers

The shrinking number of new infections in former coronavirus hot spots, including Britain, China and many of the hardest-hit regions in the United States, may be...
Mid-Day

DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human...
Mid-Day


Tweets about this